ArticleEuropean radiology2026

Early, delayed, or combined contrast-enhanced mammography for detecting residual disease after neoadjuvant chemotherapy in breast cancer.

Chiara Bellini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.